|
|
Post by brentie on Mar 24, 2016 11:51:27 GMT -5
|
|
|
|
Post by kc on Mar 24, 2016 11:58:22 GMT -5
Thanks Brentie!
Your image from the web site is much nicer and refined. I hope we see something tied to Bluhale and perhaps even spirometer.
|
|
|
|
Post by mnkdnewbie on Mar 24, 2016 19:14:51 GMT -5
|
|
|
|
Post by patten1962 on Mar 25, 2016 5:48:24 GMT -5
Dexcom has data which is why Google wants the Dexcom partnership. Dexcom will already has an app that will act as a receiver via bluetooth for the sensor so it is not a stretch to then push that data up to Google. Google then gets to look at the data from thousands of diabetics and sifts that for the actionable data. That's my bet as it fits all parties interests. Mannkind has no data stream to share so Google are not be interested in them. Good points. But I still think RLS is Google Life Sciences. I am not pumping. This is what I believe! |
|
|
|
Post by dreamboatcruise on Mar 25, 2016 12:24:33 GMT -5
Dexcom has data which is why Google wants the Dexcom partnership. Dexcom will already has an app that will act as a receiver via bluetooth for the sensor so it is not a stretch to then push that data up to Google. Google then gets to look at the data from thousands of diabetics and sifts that for the actionable data. That's my bet as it fits all parties interests. Mannkind has no data stream to share so Google are not be interested in them. It is only a stretch in the legal sense given that HIPAA imposes a lot of controls on patient health data. Unlike other personal info such as your shopping habits that can be shared widely every time you press a button without reading fine print, each patient would need to give explicit consent for exactly what Google planned to do with the data. That said, Google's experience in analytics isn't necessarily going to catapult them ahead in looking at blood glucose measurements and predicting what should be done. That isn't a job of connecting the dots in a mass of unstructured information. Interpreting BG readings has to be done in the context of modeling human physiology... at this point it would seem a stretch for Google's data analytics to infer the processes of the endocrine system from Dexcom data logs. This is why in my opinion, the type of thing you seem to be hoping for from Google is more likely to first come from companies that are specifically looking into this issue... i.e. the ones trying to create artificial pancreas. |
|
|
|
Post by matt on Mar 25, 2016 15:07:54 GMT -5
Its not that bad, both HIPAA and the European Privacy Directive focus on personally identifying information. If what gets collected is dose response characteristics for obese, females, between 50-70 years of age with insulin dependency, that is not personally identifying information because there are lots of obese females of that age. Link a name, SSN, or a patient ID of some type to that data and it becomes personally identifying. The trick is having a clean database that you can data mine and without seeing the raw patient level data is hard to prevent corruption of the database; just ask any clinical trial coordinator.
|
|
|
|
Post by kc on Mar 25, 2016 16:15:24 GMT -5
Dexcom has data which is why Google wants the Dexcom partnership. Dexcom will already has an app that will act as a receiver via bluetooth for the sensor so it is not a stretch to then push that data up to Google. Google then gets to look at the data from thousands of diabetics and sifts that for the actionable data. That's my bet as it fits all parties interests. Mannkind has no data stream to share so Google are not be interested in them. We all will be very happy if your comment turns out to be correct. From your lips to Google's ear. |
|
|
|
Post by dreamboatcruise on Mar 25, 2016 17:03:24 GMT -5
Good points. But I still think RLS is Google Life Sciences. I am not pumping. This is what I believe! We all will be very happy if your comment turns out to be correct. From your lips to Google's ear. I'm not even sure why our happiness should be different. As long as it turns out it is a company with credible funding/plan (no reason to believe it isn't), then the expectation would be that success and therefore milestone payments have reasonable chance. MNKD has a contract to deliver technology, it's not as if our first milestone would be a 5% stake in Google even on the off chance they had something to do with starting this company. I'm guessing we won't know anything more until fall. |
|
|
|
Post by 4allthemarbles on Mar 26, 2016 20:29:31 GMT -5
Did we stop talking about Vulcan or Paul Allen? Voogle? (That's a combination...)
|
|
|
|
Post by fofos2000i on Mar 31, 2016 3:17:26 GMT -5
|
|
|
|
Post by peppy on Mar 31, 2016 4:00:32 GMT -5
fofos, once again thank you.
In fine company.
looking it over and the thread over, the words, "the prince is having a ball" came to mine. I wonder if MNKD is Cinderella. ( One of my favorite stories and musicals.)
|
|
|
|
Post by fofos2000i on Mar 31, 2016 4:32:29 GMT -5
fofos, once again thank you.
In fine company.
looking it over and the thread over, the words, "the prince is having a ball" came to mine. I wonder if MNKD is Cinderella. ( One of my favorite stories and musicals.)
i have to say Cinderella doesn't come to mind but i m happy it came to you , as it should ! |
|
|
|
Post by stoxx on Mar 31, 2016 7:16:25 GMT -5
So what does this mean? There is also an entry for Wesner, Gregory F. who worked as Pro Bono Counsel at the Experience Music Project; EMP Museum is a nonprofit museum, dedicated to contemporary popular culture. EMP Museum was founded by Microsoft co-founder Paul Allen in 2000.
|
|
|
|
Post by fofos2000i on Mar 31, 2016 7:48:12 GMT -5
So what does this mean? There is also an entry for Wesner, Gregory F. who worked as Pro Bono Counsel at the Experience Music Project; EMP Museum is a nonprofit museum, dedicated to contemporary popular culture. EMP Museum was founded by Microsoft co-founder Paul Allen in 2000. to me, it invalidates the bearish hypothesis that RLS is some sort of a shell company affiliated with mnkd |
|
|
|
Post by brotherm1 on Mar 31, 2016 21:15:53 GMT -5
On the mNKD Yahoo mssg board tonight it appears a couple of posters have connected dots and very possibly found a strong connection between Receptor and GTCR. GTCR has a few billion $ and is in partnership with an ex senior executive from Abbot labs and was Presiident in charge of the diabetes section for Abbot (if I got this correct). Their new company TerSera(?) will be buying and working with fda approved material or late stage development drugs/devices (again if I remember the posts correctly). The post on the Yahoo mssg board thread is titled Another Receptor Theory
|
|
